Retrospective study of tolerability and efficacy of linezolid in patients with multidrug-resistant tuberculosis (1998-2014)

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 34, Issue 2, 2016, Pages 85-90

  Ramírez Lapausa, Marta ^a   Pascual Pareja, José Francisco ^a   Carrillo Gómez, Raquel ^a   Martínez Prieto, Mónica ^a   González Ruano Pérez, Patricia ^a   Noguerado Asensio, Arturo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Adverse events; Linezolid; Multidrug resistant tuberculosis; Outcome

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PYRAZINAMIDE; PYRIDOXINE; QUINOLONE DERIVATIVE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLICULITIS; HEARING IMPAIRMENT; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; OPTIC NERVE DISEASE; PARESTHESIA; PERIPHERAL NEUROPATHY; RETROSPECTIVE STUDY; SPAIN; SPUTUM CULTURE; TINNITUS; TREATMENT OUTCOME; VOMITING; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; LINEZOLID; MALE; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84958760126     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2015.04.003     Document Type: Article

References (14)

1. R. Dietze, D. Hadad, B. McGee, L.P. Molino, E.L. Maciel, C.A. Peloquin, and et al. Early and extended early bacterial activity of linezolid in pulmonary TB Am J Respir Crit Care Med 178 2008 1180 1185
2. G.B. Migliori, B. Eker, M.D. Richardson, G. Sotgiu, J.P. Zellweger, A. Skrahina, and et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis Eur Respir J 34 2009 387 393
3. G.F. Schecter, C. Scott, L. True, A. Raftery, J. Flood, and S. Mase Linezolid in the treatment of multidrug-resistant tuberculosis CID 50 2010 49 55
4. K.F. Laserson, L.E. Thorpe, V. Leimane, K. Weyer, C.D. Mitnick, V. Riekstina, and et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis Int J Tuber Lung Dis 9 2005 640 645
5. C.Y. Chiang, D.A. Enarson, M.C. Yu, K.J. Bai, R.M. Huang, Hsu, and et al. Outcome of pulmonary multidrug-resistant tuberculosis: 6-yr follow-up study Eur Respir J 28 2006 980 985
6. F. Ntziora, and M.E. Falagas Linezolid for the treatment of patients with mycobacterial infection: a systematic review Int J Tuber Lung Dis 11 2007 606 611
7. B. Eker, J. Ortmann, G.B. Migliori, G. Sotgiu, R. Muetterlein, R. Centis, et al. German TBNET Group Multidrug and extensively drug resistant tuberculosis, Germany Emerg Infect Dis 14 2008 1700 1706
8. Z.F. Udwadia, T. Sen, and G. Moharil Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective Eur Respir J 35 2010 936 938
9. H. Cox, and N. Ford Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis Int J Tuber Lung Dis 16 2012 447 454
10. G. Soutgiu, R. Centis, L. Dámbrosio, J. Alffenaar, J. Caminero, and P. Castiglia Efficacy, safety and tolerability of Linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis Eur Respir J 40 2012 1430 1442
11. D.C. Vinh, and E. Rubinstein Linezolid: a review of safety and tolerability J Infect 59 S1 2009 S59 S74
12. R. Singla, J.A. Caminero, A. Jaiswal, N. Singla, S. Gupta, and R.K. Bali Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India Eur Respir J 39 2012 956 962
13. M. Lee, J. Lee, M.W. Carroll, H. Choi, S. Min, T. Song, and et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis N Engl J Med 367 2012 1508 1518
14. B. Spellberg, T. Yoo, and A.S. Bayer Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6 J Antimicrob Chemother 54 2004 832 835